Effectiveness of Ezetimibe or Pitavastatin calcium calcium in NASH/NAFLD patients with high cholesterol levels: a randomized controlled study

Effectiveness of Ezetimibe or Pitavastatin calcium calcium in NASH/NAFLD patients with high cholesterol levels: a randomized controlled study - Effectiveness of Ezetimibe or Pitavastatin calcium calcium in NASH/NAFLD patientslevels: a randomized controlled study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003055

Enrollment

Registered

2010-01-18

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The NASH/NAFLD patients with high cholesterol level

Interventions

pitavastatin calcium Ezetimibe

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)The patients with fatty liver 2)The patients with the level of ALT (42-120IU/L) 3)The patients with high cholesterol levels

Exclusion criteria

Exclusion criteria: 1)The patients with the use of drugs for dyslipidemia within 4 weeks 2)The patients with chronic kidney disease (serum Cre>2.0) or severe liver dysfunction 3)The patients who are pregnant or giving the breast to a baby or want to be pregnat within the period of trial. 4)The patients with cyclosporin 5)The patients with liver dysfunction by drug, alchol, virus, or autoimmnue factors.

Design outcomes

Primary

Measure	Time frame
The level of alanine aminotransferase	—

Countries

Japan

Contacts

Public ContactFumio Imazeki

Graduate School of Medicine, Chiba University Department of Medicine and Clinical Oncology

imazekif@faculty.chiba-u.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026